Evidence map›Paper›PMID 36740925›Full record

ArticleJournal of evidence-based integrative medicine

Melanogenesis Inhibitory Activity, Chemical Components and Molecular Docking Studies of

Nateelak Kooltheat, Aman Tedasen, Kenshi Yamasaki, Moragot Chatatikun

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of evidence-based integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Lyophilized Cell-Free Supernatants ofLife (Basel, Switzerland) · 2025
    Article
  2. Establishment of Callus Cultures fromMolecules (Basel, Switzerland) · 2025
    Article
  3. Anti-Melanogenic Activity of Ethanolic Extract fromAntioxidants (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nateelak KooltheatDepartment of Medical Technology, School of Allied Health Sciences, 65133Walailak University, Nakhon Si Thammarat 80161, Thailand.ORCID 0000-0001-7623-854X
Aman TedasenDepartment of Medical Technology, School of Allied Health Sciences, 65133Walailak University, Nakhon Si Thammarat 80161, Thailand.
Kenshi YamasakiDepartment of Dermatology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi 980-8575, Japan.
Moragot ChatatikunDepartment of Medical Technology, School of Allied Health Sciences, 65133Walailak University, Nakhon Si Thammarat 80161, Thailand.ORCID 0000-0003-3264-1155
Walailak University · THTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Safe depigmenting agents are currently increasing in the cosmetic or pharmaceutical industry because various compounds have been found to have undesirable side effects. Therefore, the present study aimed to investigate the melanogenesis inhibitory effects of

Indexed as

Melanoma, ExperimentalMonophenol MonooxygenaseAnimalsButanolsEtherFlavonoidsMelaninsMiceMolecular Docking SimulationButanolsEtherFlavonoidsMelaninsMonophenol Monooxygenaseantioxidant activitymelanin contentmolecular dockingphenolic contentPrunus cerasoidestyrosinase

Identifiers

PMID36740925
PMCPMC9905211
OpenAlexW4319295347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.